Thats what paid down rampers do sadly. No shame

First 198 Last

Share
Profile

Follow
LimitedEdition

110 Posts.

24

20/01/22

08:58

Post #: 58995625
Share

Originally posted by joshjay: ↑

It's obviously going to go down, everything goes up and down. you're no genius for stating that.

But how far? I think that the market has woken up to Mercedes giving Akida a shoutout... like wtf, how many components do you think they've used in that car? and they've specifically shouted out Akida for its performance.

Trust me, if you don't have shares in this company you will be kicking yourself in 5 years. it may be in a frenzy now, I feel guilty telling my mates at 60c to wait for a pullback... You can go through all of my posts on this forum, im not one of those to the moon guys, but i work in IT and have dabbled in AI, I also have a friend who works at ARM, what BRN has is magnificent. I've never said otherwise, the market just doesn't know it yet. But it's waking up.

If no one manages to match our performance and beat us to market (we are already there) we will be the processor of choice for edge devices. All CCTV cameras will have Akida in it, the dumpster that alerts to council it needs emptying, your fridge that automatically makes your shopping list, Akida. AI is coming, and it's going to take over. You just have to back the company that has made the fastest and lowest power consumption chip. Again this is something I've been saying since 2017.

if you want to make money on markets you need to see where the world is going, I see you're called stock yoda, don't mistake your ego for wisdom. Heres a couple of free tips for you. vanadium batteries and lithium recycling companies.

just read your last sentence, they don't need to raise. They have plenty of capital and can draw on LDA if they need more. Now you've confirmed that you actually know nothing about this company and are just spewing drivel

Expand

Thats what paid down rampers do sadly. No shame

BRN Price at posting: $2.13 Sentiment: Buy Disclosure: Held
2 Upvote

2 Great analysis

Reply

Top Stories

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

RCE

Recce's R327 found effective against E.coli during clinical trial

There are more pages in this discussion • 3 more messages in this thread...

First 198 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 22.0¢		Change -0.005(2.22%)		Mkt cap ! $408.3M

Open	High	Low	Value	Volume
22.5¢	22.5¢	21.8¢	$1.107M	5.019M

Buyers (Bids)

No.	Vol.	Price($)
6	110458	22.0¢

Sellers (Offers)

Price($)	Vol.	No.
22.5¢	355185	24

View Market Depth

No.	Vol.	Price($)
4	62894	0.220
14	327682	0.215
18	373513	0.210
22	841623	0.205
58	1855008	0.200

Price($)	Vol.	No.
0.225	153131	14
0.230	555942	14
0.235	384447	13
0.240	378618	12
0.245	587269	12

Last trade - 16.10pm 28/06/2024 (20 minute delay)

BRN (ASX) Chart

Thats what paid down rampers do sadly. No shame

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thats what paid down rampers do sadly. No shame

Top Stories

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News